Upgrade to SI Premium - Free Trial

Bayer AG (BAYRY)

13.39 +0.26 (1.98%)

Chart
Today 6M 1Y 5Y

Latest Headlines

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters July 23, 2026 1:03 PM - BizWire Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials July 17, 2026 8:30 AM - BizWire Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming July 14, 2026 8:10 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays July 14, 2026 4:51 AM - StreetInsider Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at Morgan Stanley July 9, 2026 7:42 AM - StreetInsider Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR55 at Berenberg July 8, 2026 4:41 AM - StreetInsider The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials July 7, 2026 10:00 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR62.50 at Goldman Sachs July 6, 2026 8:26 AM - StreetInsider Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart July 2, 2026 8:00 AM - BizWire Deutsche Bank Upgrades Bayer AG (BAYN:GR) (BAYRY) to Buy July 2, 2026 3:54 AM - StreetInsider Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon July 1, 2026 6:33 PM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR49 at BMO Capital June 30, 2026 8:48 AM - StreetInsider Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR46 at Jefferies June 26, 2026 4:57 AM - StreetInsider Bayer and Iambic partner on AI-driven small molecule drug discovery June 22, 2026 8:01 AM - StreetInsider Bayer and Iambic Collaborate to Advance Drug Discovery with AI June 22, 2026 8:00 AM - BizWire UBS says we are entering a catalyst rich period for this big pharma stock June 21, 2026 10:00 AM - StreetInsider Bayer names Kacy Perry head of Crop Science Canada June 18, 2026 3:22 PM - StreetInsider Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada June 18, 2026 3:22 PM - BizWire Bayer completes $300M acquisition of Perfuse Therapeutics June 17, 2026 2:30 AM - StreetInsider Bayer Completes Acquisition of Perfuse Therapeutics June 17, 2026 2:30 AM - BizWire Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief June 16, 2026 10:00 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR40.50 at Berenberg June 15, 2026 5:19 AM - StreetInsider Bayer receives FDA approval for lowest-dose MRI contrast agent June 15, 2026 2:30 AM - StreetInsider Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions June 15, 2026 2:30 AM - BizWire Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business June 9, 2026 9:00 AM - BizWire Bayer names new consumer health division leaders to accelerate growth June 8, 2026 8:00 AM - StreetInsider Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth June 8, 2026 8:00 AM - BizWire Bayer's KERENDIA shows kidney benefits in non-diabetic patients June 5, 2026 6:41 AM - StreetInsider Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disea June 5, 2026 6:40 AM - BizWire Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026 June 2, 2026 8:00 AM - BizWire Barclays on Bayer AG (BAYN:GR) (BAYRY): 'Conditional transfer of settlement to federal level adds noise' June 2, 2026 5:16 AM - StreetInsider ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial May 30, 2026 5:24 PM - BizWire UBS Reiterates Buy Rating on Bayer AG (BAYN:GR) (BAYRY) May 28, 2026 11:06 AM - StreetInsider Morgan Stanley continues to see "material upside" in this big pharma stock May 26, 2026 4:00 PM - StreetInsider Bayer to present cancer trial data at ASCO 2026 meeting May 21, 2026 8:00 AM - StreetInsider ASCO 2026: Bayer to Present New Data Across Oncology Portfolio May 21, 2026 8:00 AM - BizWire Bayer's KERENDIA gets FDA priority review for type 1 diabetes treatment May 21, 2026 2:30 AM - StreetInsider Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease May 21, 2026 2:30 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR50 at Barclays May 19, 2026 5:04 AM - StreetInsider FDA grants priority review for Bayer's asundexian stroke drug May 19, 2026 2:30 AM - StreetInsider Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack May 19, 2026 2:30 AM - BizWire FDA grants priority review for Bayer's HYRNUO lung cancer application May 18, 2026 8:41 AM - StreetInsider U.S. FDA Grants Priority Review to Supplemental New Drug Application for HYRNUO® (sevabertinib) Under Investigation as a First-Line Treatment of HER2-Mutated Non-Small Cell Lung Cancer May 18, 2026 8:41 AM - BizWire AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer May 15, 2026 11:10 AM - BizWire Bayer Introduces Midol® in Motion, Empowering Menstruators to Find PMS Relief Through Movement May 15, 2026 9:01 AM - BizWire Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities May 13, 2026 9:04 AM - BizWire Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis May 7, 2026 2:30 AM - BizWire Bayer to acquire Perfuse Therapeutics for up to $2.45 billion May 6, 2026 2:30 AM - StreetInsider Bayer to acquire Perfuse Therapeutics for up to $2.45 billion May 6, 2026 2:30 AM - StreetInsider Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline May 6, 2026 2:30 AM - BizWire New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing April 29, 2026 8:00 AM - BizWire Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian April 29, 2026 8:00 AM - BizWire Full Article List